The Association of Prescribed Opioids and Incident Cardiovascular Disease

Minhee L. Sung, Svetlana K. Eden, William C. Becker, Stephen Crystal, Meredith S. Duncan, Kirsha S. Gordon, Robert D. Kerns, Suman Kundu, Matthew Freiberg, Kaku A. So-Armah, E. Jennifer Edelman

Research output: Contribution to journalArticlepeer-review

Abstract

Opioid prescribing remains common despite known overdose-related harms. Less is known about links to nonoverdose morbidity. We determined the association between prescribed opioid receipt with incident cardiovascular disease (CVD) using data from the Veterans Aging Cohort Study, a national prospective cohort of Veterans with/without Human Immunodeficiency Virus (HIV) receiving Veterans Health Administration care. Selected participants had no/minimal prior exposure to prescription opioids, no opioid use disorder, and no severe illness 1 year after the study start date (baseline period). We ascertained prescription opioid exposure over 3 years after the baseline period using outpatient pharmacy fill/refill data. Incident CVD ascertainment began at the end of the prescribed opioid exposure ascertainment period until the first incident CVD event, death, or September 30, 2015. We used adjusted Cox proportional hazards regression models with matching weights using propensity scores for opioid receipt to estimate CVD risk. Among 49,077 patients, 30% received opioids; the median age was 49 years, 97% were male, 49% were Black, and 47% were currently smoking. Prevalence of hypertension, diabetes, current smoking, alcohol and cocaine use disorder, and depression was higher in patients receiving opioids versus those not but were well-balanced by matching weights. Unadjusted CVD incidence rates per 1,000-person-years were higher among those receiving opioids versus those not: 17.4 (95% confidence interval [CI], 16.5–18.3) versus 14.7 (95% CI, 14.2–15.3). In adjusted analyses, those receiving opioids versus those not had an increased hazard of incident CVD (adjusted hazard ratio 1.16 [95% CI, 1.08–1.24]). Prescribed opioids were associated with increased CVD incidence, making opioids a potential modifiable CVD risk factor. Perspective: In a propensity score weighted analysis of Veterans Administration data, prescribed opioids compared to no opioids were associated with an increased hazard of incident CVD. Higher opioid doses compared with lower doses were associated with increased hazard of incident CVD. Opioids are a potentially modifiable CVD risk factor.

Original languageEnglish
Article number104436
JournalJournal of Pain
Volume25
Issue number5
DOIs
StatePublished - May 2024

Bibliographical note

Publisher Copyright:
© 2024

Funding

This work was funded by support from the National Institute on Drug Abuse ( 5R01DA040471 , 1R01DA047347 ) and the National Institute on Alcohol Abuse and Alcoholism ( 5U01AA020790 ). M.L. Sung was supported by the Department of Veterans Affairs (VA), Veterans Health Administration, VISN 1 Career Development Award. No conflicts of interest to report.

FundersFunder number
National Institute on Drug Abuse1R01DA047347, 5R01DA040471
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism5U01AA020790
National Institute on Alcohol Abuse and Alcoholism
U.S. Department of Veterans Affairs
Office of Health Services Research and Development

    Keywords

    • Opioids
    • cardiovascular disease
    • pain
    • propensity score
    • prospective cohort

    ASJC Scopus subject areas

    • Neurology
    • Clinical Neurology
    • Anesthesiology and Pain Medicine

    Fingerprint

    Dive into the research topics of 'The Association of Prescribed Opioids and Incident Cardiovascular Disease'. Together they form a unique fingerprint.

    Cite this